版权说明 操作指南
首页 > 成果 > 详情

Astragaloside IV prevents liver fibrosis by blocking glycolysis-mediated macrophage M1 polarization

认领
导出
Link by DOI
反馈
分享
QQ微信 微博
成果类型:
期刊论文
作者:
Hu, Yutong;Kuang, Ming;Song, Hao;Tan, Yang;Zhou, Feng;...
通讯作者:
Pei, Gang;Jiao, LJ
作者机构:
[Hu, Yutong; Song, Hao; Tan, Yang; Zhou, Feng; Jiao, Luojia; Kuang, Ming; Pei, Gang; Pei, G] Hunan Univ Chinese Med, Changsha 410000, Peoples R China.
[Hu, Yutong; Song, Hao; Tan, Yang; Zhou, Feng; Kuang, Ming; Pei, Gang] Hunan Univ Chinese Med, Coll Pharm, Changsha 410000, Peoples R China.
[Hu, Yutong; Song, Hao; Tan, Yang; Zhou, Feng; Kuang, Ming; Pei, Gang] Educ Dept Hunan Prov, Key Lab Modern Res TCM, Changsha 410000, Peoples R China.
通讯机构:
[Jiao, LJ ; Pei, G] H
Hunan Univ Chinese Med, Changsha 410000, Peoples R China.
语种:
英文
关键词:
Astragaloside IV;FoxO1;Glycolysis;Liver injury;Macrophages
期刊:
European Journal of Pharmacology
ISSN:
0014-2999
年:
2025
卷:
995
页码:
177353
基金类别:
Innovative Research Group Project of the National Natural Science Foundation of China National Natural Science Foundation of China#&#&#82174271
机构署名:
本校为第一且通讯机构
院系归属:
药学院
摘要:
Hepatic fibrosis is a late-stage process of many chronic liver diseases. Blocking the fibrosis process will be beneficial to the treatment and recovery of the disease. Hepatic macrophages are a remarkably heterogeneous population of immune cells that play multiple functions in homeostasis and are central to liver fibrosis. Glycolysis-mediated macrophage metabolic reprogramming leads to an increase in the proportion of M1 macrophages and the release of pro-inflammatory cytokines. The present study aimed to investigate the therapeutic effect and mechanism of Astragaloside IV (AS-IV) against carb...

反馈

验证码:
看不清楚,换一个
确定
取消

成果认领

标题:
用户 作者 通讯作者
请选择
请选择
确定
取消

提示

该栏目需要登录且有访问权限才可以访问

如果您有访问权限,请直接 登录访问

如果您没有访问权限,请联系管理员申请开通

管理员联系邮箱:yun@hnwdkj.com